Key result
Elevated CT central clot score predicts ~10% higher 30-day PE-related mortality.
Why the study?
The predictive value of existing CT obstruction scores compared to a new central clot score for 30-day mortality after acute pulmonary embolism was unclear.
Does a central clot score on CT predict 30-day mortality in patients with acute pulmonary embolism?
Cohort (n=125)
Single-blind (image readers blinded to clinical data and outcomes)
No
Does a central clot score on CT predict 30-day mortality in patients with acute pulmonary embolism?
Odds Ratio: 1.1 (95% CI 1–1.16)
p-value: p=<0.003
An in-house developed central clot score on CT is a strong independent predictor of 30-day PE-related mortality, potentially outperforming existing clot scores for risk stratification.
Central clot score independently predicted 30-day PE mortality; hypothesis-generating for CT risk stratification, requiring prospective validation before clinical use.
INTRODUCTION: The severity of acute pulmonary embolism can be assessed with computed tomography (CT) using clot burden estimation. We compared the existing CT obstruction scores with an in-house developed central clot score for the prediction of 30-day pulmonary embolism (PE)-related mortality. MATERIALS AND METHODS: In 125 consecutive patients [47 men, 78 women; mean age +/- standard deviation (SD, 60.4 years +/- 16.6] with acute PE, 2 readers in consensus assessed the severity of PE with 2 existing clot scoring systems (Mastora and Qanadli) and central clot score. The right ventricular dysfunction was assessed by right ventricular diameter (RVD), left ventricular diameter (LVD), ventricular ratio (VR) and septal deviation. Univariate and multivariate regression analysis were performed to correlate these parameters and 30-day PE-related mortality. RESULTS: Ten patients (8%) died of PE within 30 days following CT and 115 patients did not have PE-related death outcome. There was a significant difference in all 3 clot scores, LVD and VR between patients with 30-day PE-related death and those without (P < or =0.001-0.02). Univariate regression analysis showed that all three clot scores and LVD were predictors of PE death, however with multivariate analysis, only central clot score showed significant correlation with 30-day PE death [Odds ratio (OR), 1.1; 96% CI, 1-1.16; P <0.003]. A central clot index of 53% had 100% sensitivity, 76.5% specificity, 23.5% positive predictive value and 98% negative predictive value for 30-day PE death. CONCLUSION: Central clot score is a strong predictor of 30-day PE death and may therefore allow therapy and risk stratification in patients with acute PE.
No takes yet. Share an insight, caveat, or question.
Venkatesh et al. (2010) conducted a cohort in Acute pulmonary embolism (n=125). Central clot score vs. Mastora and Qanadli scoring systems was evaluated on 30-day PE-related mortality (OR 1.1, 95% CI 1-1.16, p=<0.003). An elevated central clot score on computed tomography was a significant independent predictor of 30-day pulmonary embolism-related mortality (OR 1.1).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: